Top

Journal of Medical Case Reports

Published in:

Open Access 01-12-2023 | Ectopic Pregnancy | Case report

Low-dose methotrexate-induced renal failure in a patient with ectopic pregnancy: a case report

Authors: Lili Zhang, Chen Liu, Ling Xiao, Yun Liu

Published in: Journal of Medical Case Reports | Issue 1/2023

Abstract

Background

Methotrexate is an anticancer drug from the antimetabolite class. It is also used in gynecology and obstetrics for the medical treatment of ectopic pregnancies. Low-dose methotrexate-induced adverse toxic effects are rare. We report a case of toxic effect associated with severe renal insufficiency induced by LD-MTX (Low-Dose Methotrexate) for ectopic pregnancy.

Case presentation

A 46-year-old Chinese woman was in an operation for an ectopic pregnancy of tubal interstitial pregnancy. The embryo villus was so little that we were not sure if it was evacuated, then it was followed with 50 mg methotrexate injection of intramuscular adjacent the uterine horn in the operation. 48 hour later after injection the patient presented with renal failure. The personalized genetic testing showed that MTHFR (677C > T) and ABCB1 (3435T > C) were detected. Gradually, the symptoms improved after calcium leucovorin (CF) rescue, continuous renal replacement therapy (CRRT), promoting blood system regeneration, and multiple supportive treatments.

Conclusions

When toxic effects are suspected, detecting the polymorphisms of an MTHFR gene and monitoring MTX concentration in blood could assist us to formulate individualized and active treatments. The management should be multidisciplinary and as much as possible within an intensive care unit.

Hajenius PJ, Engelsbel S, Mol BW, et al. Randomised trial of systemic methotrexate versus laparoscopic salpingostomy in tubal pregnancy. Lancet. 1997;350(9080):774–9.CrossRefPubMed

Howard SC, Mccormick J, Pui CH, Buddington RK, Harvey RD. Preventing and managing toxicities of high-dose methotrexate. Oncologist. 2016;21:1471–82. https://doi.org/10.1634/Theoncologist.2015-0164.CrossRefPubMedPubMedCentral

Brown P, Shah B, Advani A, et al. Acute lymphoblastic leukemia, version 2.2021, Nccn clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19:1079–109. https://doi.org/10.6004/Jnccn.2021.0042.CrossRefPubMed

Mm A, Ea A-S, Ja A-H, Mb A, Aa A, Me I. Treatment of ectopic pregnancy with a single intramuscular dose of methotrexate. Arch Gynecol Obstet. 2003;268(3):181–3.CrossRef

Yu H, Wang W, Liang H, Wang K, Ling B. Severe adverse toxic effects of low-dose methotrexate treatment on an ectopic pregnancy patient with methylenetetrahydrofolate reductase mutations: a case report. Front Med (Lausanne). 2021;8: 738315.CrossRefPubMed

Shaikh N, Sardar M, Raj R, Jariwala P. A rapidly fatal case of low-dose methotrexate toxicity. Case Rep Med. 2018;2018:9056086.CrossRefPubMedPubMedCentral

Shao W, Yuan Y, Li Y. Association between Mthfr C677t polymorphism and methotrexate treatment outcome in rheumatoid arthritis patients: a systematic review and meta-analysis. Genet Test Mol Biomarkers. 2017;21(5):275–85.CrossRefPubMed

Yao P, He X, Zhang R, Tong R, Xiao H. The influence of mthfr genetic polymorphisms on adverse reactions after methotrexate in patients with hematological malignancies: a meta-analysis. Hematology. 2019;24(1):10–9.CrossRefPubMed

Diagnosis and management of ectopic pregnancy: Green-Top Guideline No. 21. Bjog. 2016. 123(13): E15-E55.

10.

Practice Committee of American Society For Reproductive Medicine. Medical treatment of ectopic pregnancy: a committee opinion. Fertil Steril. 2013; 100(3): 638-44.

11.

Shafie M, Abbaszadeh M, Sharifi F. Hyperpigmentation, severe alopecia, and six days of instability in a case of severe methotrexate hypersensitivity reaction. Daru. 2021;29:205–9. https://doi.org/10.1007/S40199-020-00379-0.CrossRefPubMedPubMedCentral

12.

Sc S, Yk Y, Ps C, Ec L. Methotrexate-induced pancytopenia in a patient with ectopic pregnancy. Arch Med Sci. 2018;14:475–6. https://doi.org/10.5114/Aoms.2016.58844.CrossRef

13.

Willner N, Storch S, Tadmor T, Schiff E. Almost a tragedy: severe methotrexate toxicity in a hemodialysis patient treated for ectopic pregnancy. Eur J Clin Pharmacol. 2014;70:261–3. https://doi.org/10.1007/S00228-013-1608-3.CrossRefPubMed

14.

Gaïes E, Ben Sassi M, Charfi R, et al. Fatal methotrexate toxicity in a patient treated for an ectopic pregnancy. Therapie. 2016;71:348–50. https://doi.org/10.1016/J.Therap.2015.12.006.CrossRefPubMed

15.

Kelly H, Harvey D, Moll S. A cautionary tale: fatal outcome of methotrexate therapy given for management of ectopic pregnancy. Obstet Gynecol. 2006;107:439–41. https://doi.org/10.1097/01.Aog.0000172374.72125.3e.CrossRefPubMed

16.

Isaacs JD Jr, Mcgehee RP, Cowan BD. Life-threatening neutropenia following methotrexate treatment of ectopic pregnancy: a report of two cases. Obstet Gynecol. 1996;88:694–6. https://doi.org/10.1016/0029-7844(96)00252-9.CrossRefPubMed

17.

Dasari P, Sagili H. Life-threatening complications following multidose methotrexate for medical management of ectopic pregnancy. BMJ Case Rep. 2012. https://doi.org/10.1136/Bcr-03-2012-6023.CrossRefPubMedPubMedCentral

18.

Refeno V, Rasamimanana NG, Abasse BA, Ramarokoto M, Fanomezantsoa M, Randaoharison PG. Methotrexate-induced toxidermia and pancytopenia in a patient with ectopic pregnancy: a case report. J Med Case Rep. 2021;15:579. https://doi.org/10.1186/S13256-021-03111-X.CrossRefPubMedPubMedCentral

19.

Bannwarth B, Labat L, Moride Y, Schaeverbeke T. Methotrexate in rheumatoid arthritis. An Update Drugs. 1994;47:25–50. https://doi.org/10.2165/00003495-199447010-00003.CrossRefPubMed

20.

Bressolle F, Bologna C, Kinowski JM, Sany J, Combe B. Effects of moderate renal insufficiency on pharmacokinetics of methotrexate in rheumatoid arthritis patients. Ann Rheum Dis. 1998;57(2):110–3.CrossRefPubMedPubMedCentral

21.

Abdelsalam MS, Althaf MM, Alfurayh O, Maghfoor I. The utility of online haemodiafiltration in methotrexate poisoning. BMJ Case Rep. 2014. https://doi.org/10.1136/Bcr-2014-203530.CrossRefPubMedPubMedCentral

22.

Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10(1):111–3.CrossRefPubMed

23.

Deng J, Chen L, Xue H, Zeng FX, Niu PG, Shi DH. Contribution of genetic polymorphism of methylene tetrahydrofolate reductase on the effect of methotrexate in ectopic pregnancy patients. J Clin Lab Anal. 2020;34(1):E23030.CrossRefPubMed

24.

Song Z, Hu Y, Liu S, et al. Medication therapy of high-dose methotrexate: an evidence-based practice guideline of the division of therapeutic drug monitoring, Chinese pharmacological society. Br J Clin Pharmacol. 2022;88:2456–72. https://doi.org/10.1111/Bcp.15134.CrossRefPubMed

Title: Low-dose methotrexate-induced renal failure in a patient with ectopic pregnancy: a case report
Authors: Lili Zhang
Chen Liu
Ling Xiao
Yun Liu
Publication date: 01-12-2023
Publisher: BioMed Central
Keywords: Ectopic Pregnancy
Methotrexate
Methotrexate
Published in: Journal of Medical Case Reports / Issue 1/2023
Electronic ISSN: 1752-1947
DOI: https://doi.org/10.1186/s13256-023-03834-z

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Low-dose methotrexate-induced renal failure in a patient with ectopic pregnancy: a case report

Abstract

Background

Case presentation

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Case presentation

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2023

Sclerosing angiomatoid nodular transformation of the spleen

Atypical presentation of mpox in Irrua environs: a case report

Midgut volvulus due to congenital malrotation in an adult: a case report

Progressive encephalomyelitis with rigidity and myoclonus (PERM) associated with urothelial carcinoma

Mifepristone induced liver injury in a patient with Cushing syndrome: a case report and review of the literature

Metachronous immune-related adverse events involving type 1 diabetes and isolated adrenocorticotropic hormone deficiency associated with pembrolizumab monotherapy for metastatic head and neck cancer: a case report